Forum for discussing local and world politics and issues. All views are welcomed. Let your opinions be heard on current news and politics.
All standard guidelines apply to this board, No Flaming, No Taunting, No Foul Language,No sexual innuendos,etc..
As politics can be a volatile subject, please consider how you would feel if your comment were directed toward yourself.
Any post deemed to be in violation of guidelines will be deleted or edited without warning or notification. Any continued misbehavior will result in a ban or hidden status, so please play nice!!!
*"Moderators are here for a reason. If a moderator (or Global Moderator or Fencer) requests that a discussion on a certain subject to cease - for whatever reason - please respect these wishes. Failure to do so may result in being hidden, or banned."
“This resolution protects the FDA in its vital mission of ensuring that drugs are safe and effective. When manufacturers undermine the FDA’s rules, they interfere with a doctor’s judgment and can put patient health at risk,” commented Michael L. Levy, U.S. Attorney for the Eastern District of Pennsylvania. “The public trusts companies to market their drugs for uses that FDA has approved, and trusts that doctors are using independent judgement. Federal health dollars should only be spent on treatment decisions untainted by misinformation from manufacturers concerned with the bottom line.”
“This settlement demonstrates the ongoing efforts to pursue violations of the False Claims Act and recover taxpayer dollars for the Medicare and Medicaid programs,” noted Jim Zerhusen, U.S. Attorney for the Eastern District of Kentucky.
“This historic settlement emphasizes the government’s commitment to corporate and individual accountability and to transparency throughout the pharmaceutical industry,” said Daniel R. Levinson, Inspector General of the United States Department of Health and Human Services. “The corporate integrity agreement requires senior Pfizer executives and board members to complete annual compliance certifications and opens Pfizer to more public scrutiny by requiring it to make detailed disclosures on its Web site. We expect this agreement to increase integrity in the marketing of pharmaceuticals.”
“The off-label promotion of pharmaceutical drugs by Pfizer significantly impacted the integrity of TRICARE, the Department of Defense’s healthcare system,” said Sharon Woods, Director, Defense Criminal Investigative Service. “This illegal activity increases patients’ costs, threatens their safety and negatively affects the delivery of healthcare services to the over nine million military members, retirees and their families who rely on this system. Today’s charges and settlement demonstrate the ongoing commitment of the Defense Criminal Investigative Service and its law enforcement partners to investigate and prosecute those that abuse the government’s healthcare programs at the expense of the taxpayers and patients.”
“Federal employees deserve health care providers and suppliers, including drug manufacturers, that meet the highest standards of ethical and professional behaviour,” said Patrick E. McFarland, Inspector General of the U.S. Office of Personnel Management. “Today’s settlement reminds the pharmaceutical industry that it must observe those standards and reflects the commitment of federal law enforcement organizations to pursue improper and illegal conduct that places health care consumers at risk.”
“Health care fraud has a significant financial impact on the Postal Service. This case alone impacted more than 10,000 postal employees on workers’ compensation who were treated with these drugs,” said Joseph Finn, Special Agent in Charge for the Postal Service’s Office of Inspector General. “Last year the Postal Service paid more than $1 billion in workers’ compensation benefits to postal employees injured on the job.”
(peida) Kui Sa tahad kindla mängutasemega vastast, siis võid uue partii loomisel määrata tema BKR vahemiku. Siis teised mängijad ei näe ega saa seda kutset vastu võtta. (Katechka) (näita kõiki vihjeid)